|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 215/38 | |
| C07D 413/12 | |||
| C07D 409/12 | |||
| C07D 401/12 | |||
| C07D 417/12 | |||
| C07D 405/12 | |||
| A61K 31/4709 |
| (11) | Number of the document | 1876174 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07118193.7 |
| Date of filing the European patent application | 2004-07-15 | |
| (97) | Date of publication of the European application | 2008-01-09 |
| (45) | Date of publication and mention of the grant of the patent | 2009-11-11 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 0316915 | 2003-07-18 | GB |
| (72) |
Bergauer, Markus, IT
Bertani, Barbara, IT
Biagetti, Matteo, IT
Bromidge, Steven, Mark, IT
Falchi, Alessandro, IT
Leslie, Colin, Philip, IT
Merlo, Giancarlo, IT
Pizzi, Domenica, Antonia, IT
Rinaldi, Marilisa, IT
Stasi, Luigi, IT
Tibasco, Jessica, IT
Vong, Antonio, Kuok, Keong, GB
Ward, Simon, Edward, GB
|
| (73) |
GLAXO GROUP LIMITED,
Glaxo Wellcome House, Berkeley Avenue,, Greenford, Middlesex UB6 0NN,
GB
|
| (54) | Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors |
| Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors |